Evidence map›Paper›PMID 10395076›Full record

ArticleMolecular and cellular biochemistry1999

Role of protein kinase C and 72 kDa heat shock protein in ischemic tolerance following heat stress in the rat heart.

R C Kukreja, Y Z Qian, S Okubo, E E Flaherty

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 42 citations in OpenAlex.

  1. Heat shock protein 70 is induced by pepsin via MAPK signaling in human nasal epithelial cells.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2019
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

R C KukrejaDepartment of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
Y Z Qian
S Okubo
E E Flaherty
Virginia Commonwealth University Medical Center · US

Funding

Protection against Doxorubicin-Induced CardiomyopathyR37HL051045 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C · 2006 to 2015
$3.8M
MOLECULAR MECHANISMS OF DELAYED PRECONDITIONINGR01HL059469 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C. · 1998 to 2006
$2.4M
SIGNALING MECHANISMS IN PHARMACOLOGICAL PRECONDITIONINGR01HL051045 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C. · 1995 to 2004
$1.4M
NHLBI NIH HHS HL 51045NHLBI NIH HHS HL 59469
6 · The paper itself

Abstract

Heat stress (HS) and the subsequent expression of 72 kDa heat shock protein (HSP 72) has been shown to enhance post-ischemic functional recovery and reduce infarct size. Because the synthesis of heat shock proteins involves activation of heat shock transcription factors through phosphorylation, we hypothesized that inhibition of protein kinase C (PKC) would block HS mediated protection and expression of HSP 72 in the heart. Five groups of rats were studied (1) Sham anesthetized, (2) HS group--animals were heat shocked by raising the whole body core temperature to 42 degrees C for 15 min, (3) Vehicle group--HS rats treated with 50% DMSO in saline, (4) PKC inhibitor-treated group--specific PKC antagonist, chelerythrine chloride (5 mg/kg, i.p) given 30 min prior to HS and (5) Vehicle treated control--non-HS rats treated with vehicle prior to ischemia/reperfusion. Hearts were subjected to 30 min of regional ischemia and 90 min of reperfusion 24 h after HS. Risk area was delineated by injection of 10% Evan's blue and infarct size determined using computer morphometry of tetrazolium stained sections. Infarct size (% area at risk) reduced significantly from 49.4 +/- 2.3% (n = 7) in sham to 10.0 +/- 2.5% (p < 0.01) and 9.1 +/- 3.0% in HS and vehicle treated HS groups respectively (p < 0.05) Treatment with chelerythrine prior to HS increased infarct size to 49.4 +/- 2.3% (p < 0.05). Infarct size in chelerythrine-treated non-HS ischemic/reperfused heart was 40.7 +/- 5.4%, which did not differ significantly from vehicle-treated sham group. Western blot analysis demonstrated marked increase in HSP 72 in HS groups (with or without vehicle treatment) and pretreatment with chelerythrine chloride failed to inhibit the expression of HSP 72. The results suggest that HS-induced ischemic tolerance is mediated via PKC pathway and this protection does not appear to be directly related to the expression of HSP 72 in rat heart.

Indexed as

AnimalsHeat-Shock ProteinsHeat Stress DisordersHemodynamicsHSP72 Heat-Shock ProteinsMaleMyocardial InfarctionMyocardial IschemiaProtein Kinase CRatsRats, Sprague-DawleyHeat-Shock ProteinsHSP72 Heat-Shock ProteinsProtein Kinase C

Identifiers

PMID10395076
OpenAlexW6992788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.